Randomized controlled trial of ventricular tachycardia treatment by cooled tip catheter ablation vs drug therapy  by Epstein, A.E. et al.
Electrlcal Predlctlon of Postoperatlve Atrlal 
Flbrlllatlon From COntlnUOUs Recordings of 
Atrlal Electragrams 
N. Guptn, K.A. Mowray, T.A. Grady, R.A. Schwclkart, R.S ~ll[;lnslini, 
V.I. HcrktHs, S.N. Fmnch , P.M. McCnrlhy, M.K. Chung. The CleveJarld 
~ljidc Formdallon. C/ova/and, Oh/o, USA; fMed/mn/c, II-IO., M/nnenPo//s. 
Mlnnesofn, USA 
The nblllty ta pradlct ntrlnl llbrlllatlon (AF) altar cnrdlsc surgary may halp ta 
tnrgat prophylncllc tharnplae. Wo aoughl to dotermlno eloclrlcnl mnrkara that 
cnuld pradlct tha onaat of poatcparnllvo AF. 
M~fhads: Surfnca and Intr~ntrlnl olnctrogmms wara rocardod for 3 dnys 
alfor coranny bypnaa surgery In 28 pntlonta. A dunl~chombar pncsmokar 
(Madtronlc Tharn DR MN 4040) with nutomnllc moda swllchlng cnpnbllltlaa 
WBQ used and detected 9 nuatolnod run8 al AF In 5 pt@. 
R~su//~ Fraquancy cl ntrlnl aclapy (APB@ lncransad during the haur 
procodlng AF (POG :I: 2781hr) vs. lho baaallna porlod, dallnad 0% lha tlmo 
parlad up to one hour procodlng Iho annat of AF (121 :I- 224lhr; p a 0.12). 
Avornga API) caupllng Intervnl during tha hour prlar tn tha ansot al AF wno 
shorter than the bnnellno parlocf (422 :b 83 ms vs. G29 .I: tlG ma: p m O.OEG). 
Avantan A.A lntatvnls (AA) wara cnlculntnd ovary 6 mln In tha haur pracadlng 
AF. Thn mann AA nlgnlllcnntly nhortonad nnd APD caunln lncrannad pnor ta 
AF (noa grnph). Tha AA nnd APL) In Iha 5 ml11 juhl prlut to AF unaot waro 
algnlllcnnlly dlffaront (p * 0.0s) lmm nil AA gruntnr lhnn 38 min. nnd APD nt 
bnaellna, mspactlvoly. 
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Cone/us/on: Chnngas In AA and APD cnn hcrnld thc ansot 01 AF In 
pntlonts nflar cnrdlnc surgaly nnd mny provldc nn lndtcnlor lor pruphylactlc 
lntonmntlons. 
1045-l 64 Atria1 Flbrlllatlon Is Common After Mlnlmaliy 
lnvaslve Direct Coronary Artery Bypass Surgery 
J.E. TomIs. M.E. Vlokn. S. Mnlhotra. B.P. Mindlch. J.S. Steinberg. St. 
Luke&-Roosove/f Hospifol Center end Columbia Univ@‘sify Co//ege of 
Physrciaris and Surgeons. New York. NY: The VaNey Hospita/, Rfdgewod, 
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Atria1 flbrlllation (AF) IS the most common nrrhylhmlo soen attor CABG 
occurrlng in 25’.-40% ot pts. Racently minimally invasive direct coronary 
srtey bypnss surgery (mIdCAB) has boon explored as en altemntlve to the 
traditional CABG. Because 01 ditforoncos In surgical nppronch and post.op 
recovery nmong the 2 procedures. we locked at the incidence of AF In 
pts undergoing midCAB and CABG. Forty-two consecutive pts undergoing 
mini-CAB were compared wilh 33 pts undergoing CABG. Baseline variables 
end post-op course sre depicted below. 
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Conc/usrons: AF is common after midCAB, and its incidence is similar to 
that In CABG pts. Although mini-CAB may offer advantages to CABG with 
respect to post-op recovery. the development of AF does not contribute to 
these advantages. 
1 1045-I 65 ( Atrial Wavelength Does Not Predict the 
Occurrence of Atrial Fibrillation After Open 
Heart Surgery 
M.H. Raitt. K. Ingram. Portland Oregon VA Medical Center. USA 
Background: Atrial fibrillabon (AF) occurs In 30% of patients that undergo 
open honrf surgary (OHS). The wavelonglh ?ypolhosls al AF stntas Ihal slow 
cancfuctlon velocity and n shoti atrlnl relractcty parlod fncllilnto tho lnltlntlon 
and malnlonnnco of AF. Wa invostlgotad tho relation botweon post op AF 
nnd an astlmato 01 tha ntrlnl wnvolangth In patients In tha first wook nftcr 
OHS. 
MO/hods: 41 patlants had F wnva trlggored slgnal averaged P wava 
durollon (SAPD) and alrlnl eflactlvo rotraclory porlod (EAP) maaaured 2.2 +Z 
1 days alter surgery. Atrlal ERP was maasurod at twice threshold al two atrIal 
altos at 2 drlvs IraIn cycle langlha using 4 oplcardlal wlres (meulla pmaonted 
nra the avarnga al lhaaa moaauremants, tha results were the same for the 
mflximum or m;nlmum valuaa). SAPD varlss lnvemaly to atrlal canductian 
valoclty thamlora tha ntrlnl wnvnlangth WRO oetlmated by the rnlio of the 
ERP to SAPD. Tho lnclcfanca 01 AF wns dolormined by ccntlnucua Helter 
mcnltorlng. 
Rasuff~: 17 pollants hod AE SAPD was longer (123 k 10 vs. 110s f 
23 p 9 0.93) but unoxpaotadly thn BRP tandad fa ba longer in patients that 
davolapad AF campnrad ta thasa that did net (259 t 26 va, 249 f 24 ms. 
p = 0.24). Aa n result, the wnvalangth erit!mnta parndaxlcally tendcd to be 
longer In potlantrr that dovctapad AF (lB31 1 0.35 va. 2-05 t 0.28 p = 0.43). 
Canclusiun: Tha tmnd al nlribl wnvalangth and ERP to be longor m 
pntlonts thnt dovotop AF nltor CHS suggests that athor factare 8uch OS tho 
dlsporalon 01 ntrlnl rolrnctarlnaaa ar the proaanca ar absence al a tnggor 
Guch ns PACe may be IIIUI~I importnnt tn datamtntng the inctdcnca a1 AF In 
this cllnlcal sttufltlon. 
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A.E. Epstein, D.J. Wilber. t-t. Calklns, J.M. Wharton. W.G. Stevenson. 
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Successful radiofrequency ablation (RFA) of ventricular tachycardia (VT) in 
patlonts (pts) with organic heart disease is much less ceriain than RFA for 
supraventrl&ar srrhythmias tend nonischemic VT. Thus, a no&\ WlhctBr with 
intomal salme cooling was developed to increase lesion size and tmprove 
efficacy. 105 pts were randomized in a clinical trial to compare cooled (C) 
RFA (n = 73) and drug therapy (DT. n = 32) The primary endpolnt was any VT 
recurrence Including those that were unmappable/untargeted. Domogrephlcs 
were similar (CRFA vs DT): age 82.5 f 19.8/88.7 f 19.8 yrs. mate gender 
92%/84%. ischemic heart disease 830/a/91 96. mean LV EF 0.31 f 0 13/0.29 
+ 0.12, #VT episodes 23 rt 5309 t dtl. W drug failures 2.5 f 1.8122 i 1.0, 
prior ICD 70%/75%. prior RFA 18%/13%. and # induced VTs 3.2 t 2.112.8 
t 1,7. Sy Intention-to-treat Kaplan-Meier analysis, VT recurred in 49% of 
the CRFA and 75?/. of DT pts at 8 mos (p = 0.0004). By intel~tion.to.treat, 
acute efficacy of CFRA (no further mappable VT) was 77%. Most imporlantly, 
the number of VT episodes in the 2 mos. following CRFA were reduced by 
~-75% in 74% 01 pts. However. only 59/73 pts (81%) actually received CRFA. 
and of those 43 (73%) had acute efficacy. with no recurrence in 28 (80%). 
Interestingly. of the 18 pts with acute inafficacy. 5 (31%) had no recurrence. 
Of 17 DT pts who crossed over to CRFA. 1407 (82%) had acute efficacy, 
9 of whom (84%) had no recurrence. Major complications occurred in 71105 
pts (2 deaths (1 stroke In control crossover, 1 MI)). 1 stroke. 1 perforalion. 
and 3 3y AV block). 
Conclusion: In this first randomized trial of CRFA in drug-resistant and 
device-failure pts with VT, recurrence was significantly lower with cooled 
ablation then with drug therapy. 
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We developed a new cardioscopic catheter ablation system to ablate my 
ocardial tissue using non-contact laser energy delivery which allows direct 
visualization of the ablation lield. We hypothesized that non-contact. pulsed 
